Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $218.3M
Liabilities Breakdown FY2011
Total Liabilities: $26.9M
Asset Breakdown
Total Assets: $218.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $58.9M | 27.0% |
| Accounts Receivable | $4.6M | 2.1% |
| Inventory | $15.5M | 7.1% |
| Property, Plant & Equipment | $18.4M | 8.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $121.0M | 55.4% |
Liabilities Breakdown
Total Liabilities: $26.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.7M | 17.7% |
| Long-Term Debt | $2.8M | 10.4% |
| Other Liabilities | $19.3M | 72.0% |